These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 7047344)
1. Insulin antibodies in juvenile diabetes mellitus. Correlations to diabetic stability, insulin requirement and duration of insulin treatment. Keilacker H; Rjasanowski I; Ziegler M; Michaelis D; Woltanski KP; Besch W Horm Metab Res; 1982 May; 14(5):227-32. PubMed ID: 7047344 [TBL] [Abstract][Full Text] [Related]
2. The role of insulin antibodies in insulin treatment of type I diabetes. Keilacker H; Rjasanowski I; Ziegler M; Michaelis D; Woltanski KP; Besch W Exp Clin Endocrinol; 1986 Jun; 87(1):79-88. PubMed ID: 3527726 [TBL] [Abstract][Full Text] [Related]
3. Total insulin levels in type 1 diabetic patients with insulin antibodies and their effect on insulin requirement and metabolic control. Hübinger A; Becker A; Gries FA Diabetes Res; 1988 Feb; 7(2):65-9. PubMed ID: 3293878 [TBL] [Abstract][Full Text] [Related]
4. Factors affecting insulin antibody binding in children with insulin-dependent diabetes mellitus. Daneman D; Fishman L; Clarson C Clin Invest Med; 1987 Sep; 10(5):480-3. PubMed ID: 3315369 [TBL] [Abstract][Full Text] [Related]
5. Insulin--binding antibodies in Nigerian diabetic patients. Bella AF; Adetuyibi A West Afr J Med; 1990; 9(4):291-4. PubMed ID: 2083207 [TBL] [Abstract][Full Text] [Related]
6. Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment. Matsuyama T; Hoffman WH; Dunbar JC; Foà NL; Foà PP Horm Metab Res; 1975 Nov; 7(6):452-6. PubMed ID: 1213649 [TBL] [Abstract][Full Text] [Related]
7. Erythrocyte insulin binding in insulin-dependent diabetes mellitus: lack of relationship to duration and control of diabetes in children and adolescents. Kappy MS; Plotnick LP; Findlay JC; Kayne RD Pediatrics; 1980 Sep; 66(3):385-90. PubMed ID: 6999446 [TBL] [Abstract][Full Text] [Related]
8. [Causes of insulin resistance in type 1 diabetes]. Waldhäusl W; Bratusch-Marrain P Wien Klin Wochenschr; 1985 Apr; 97(8):359-63. PubMed ID: 3993044 [TBL] [Abstract][Full Text] [Related]
9. 5-year follow-up study of C-peptide secretion in newly diagnosed type I diabetics: relations to HLA-phenotype, insulin requirement and metabolic control. Rjasanowski I; Michaelis D; Keilacker H; Besch W; Richter KV; Heinke P Exp Clin Endocrinol; 1987 Apr; 89(2):216-24. PubMed ID: 3301371 [TBL] [Abstract][Full Text] [Related]
10. Is there a relationship between genetically determined haptoglobin phenotype and insulin-dependent diabetes mellitus (IDDM)? Ratzmann KP; Strese J; Keilacker H; Giebelmann R; Scheibe F; Witt S Exp Clin Endocrinol; 1984 Apr; 83(2):207-15. PubMed ID: 6539222 [TBL] [Abstract][Full Text] [Related]
11. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies. Anderson OO Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962 [TBL] [Abstract][Full Text] [Related]
12. A case of slowly progressive type 1 diabetes with unstable glycemic control caused by unusual insulin antibody and successfully treated with steroid therapy. Matsuyoshi A; Shimoda S; Tsuruzoe K; Taketa K; Chirioka T; Sakamoto F; Sakakida M; Miyamura N; Araki E Diabetes Res Clin Pract; 2006 Jun; 72(3):238-43. PubMed ID: 16439034 [TBL] [Abstract][Full Text] [Related]
13. Insulin antibodies and the control of diabetes. Dixon K; Exon PD; Malins JM Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646 [TBL] [Abstract][Full Text] [Related]
14. Studies on juvenile--type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides. Schatz H; Winkler G; Jonatha EM; Pfeiffer EF Diabete Metab; 1975 Dec; 1(4):211-20. PubMed ID: 1234581 [TBL] [Abstract][Full Text] [Related]
15. Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes. Lugari R; Dell'Anna C; Ugolotti D; Dei Cas A; Barilli AL; Zandomeneghi R; Marani B; Iotti M; Orlandini A; Gnudi A Horm Metab Res; 2000 Oct; 32(10):424-8. PubMed ID: 11069208 [TBL] [Abstract][Full Text] [Related]
16. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies. Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887 [TBL] [Abstract][Full Text] [Related]
17. The influence of insulin antibodies on metabolic deterioration after interruption of continuous subcutaneous insulin infusion. Montaña E; Fernández-Castañer M; Rosel P; Gómez JM; Vinzia C; Soler J Diabete Metab; 1990; 16(3):220-5. PubMed ID: 2210017 [TBL] [Abstract][Full Text] [Related]
18. [beta-Cell residual function in juvenile diabetes mellitus (author's transl)]. Schober E; Schernthaner G; Frisch H Monatsschr Kinderheilkd; 1980 Dec; 128(12):776-9. PubMed ID: 6109242 [TBL] [Abstract][Full Text] [Related]
19. [Semisynthetic human insulin in the treatment of diabetes type I. Preliminary experience]. Vitacolonna E; Consoli A; Capani F Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1849-52. PubMed ID: 6394033 [TBL] [Abstract][Full Text] [Related]
20. Measurement of insulin in human sera using a new RIA kit. 2. Determination of free and total insulin--correlations to insulin antibody levels. Keilacker H; Besch W; Woltanski KP; Diaz-Alonso JM; Kohnert KD; Ziegler M Exp Clin Endocrinol; 1987 Dec; 90(3):271-7. PubMed ID: 3330035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]